Open AccessState Control of the Interpretation of Genomic Studies and Medical Applications in the United States of America
Author(s) -
Anzhelika Sakhipgareeva
Publication year - 2018
Publication title -
vestnik rossijskogo universiteta družby narodov. seriâ ûridičeskie nauki
Language(s) - English
Resource type - Journals
eISSN - 2408-9001
pISSN - 2313-2337
DOI - 10.22363/2313-2337-2018-22-3-328-344
Subject(s) - food and drug administration , state (computer science) , interpretation (philosophy) , control (management) , intervention (counseling) , field (mathematics) , genomic medicine , medical research , political science , data science , microbiology and biotechnology , medicine , computer science , risk analysis (engineering) , computational biology , artificial intelligence , biology , mathematics , algorithm , psychiatry , pure mathematics , programming language
This Article is devoted to the theoretical ideas about the features of state control in genomic research and medical applications in the United States of America. The purpose of this study is to examine the legal aspects of the interpretation of genomic research and medical applications in the United States of America, to study the features of the state control of medical applications, as well as companies providing services in the field of genomic research. As a result of the review, the author provides with the information about several features of the state control of the US Food and drug administration (FDA), degree of regulatory intervention in the activities of genetic research companies, identify classification of medical applications apps.